Health economic analysis orphan drug epilepsy
Third-party funded project
Project title Health economic analysis orphan drug epilepsy
Principal Investigator(s) Schwenkglenks, Matthias
Organisation / Research unit Departement Public Health / Pharmazeutische Medizin (Szucs)
Project start 17.07.2019
Probable end 31.07.2020
Status Completed

Development of a cost-effectiveness analysis framework for a novel drug used in severe forms of childhood epilepsy, analysis for the United Kingdom.

Keywords epilepsy, Dravet syndrome, drug treatment, cost-effectiveness
Financed by Private Sector / Industry

MCSS v5.8 PRO. 0.458 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |